|
Volumn 3, Issue 6, 2002, Pages 331-
|
Vaccines against dangerous infections and cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
7,12 DIMETHYLBENZ[A]ANTHRACENE;
ADJUVANT;
ANTHRAX TOXIN;
ANTHRAX VACCINE;
BACTERIAL TOXIN;
CANCER VACCINE;
CARCINOGEN;
CYTOCHROME P450;
DNA;
INACTIVATED VACCINE;
LIVE VACCINE;
PROMUTAGEN;
TULAREMIA VACCINE;
ACTIVE IMMUNIZATION;
ANIMAL CELL;
ANTHRAX;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW CELL;
CANCER IMMUNOTHERAPY;
CANCER INCIDENCE;
CANCER INHIBITION;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CHEMICAL CARCINOGENESIS;
CHROMOSOME ABERRATION;
CONTROLLED STUDY;
DRUG QUALITY;
DRUG SCREENING;
HUMAN;
LUNG CANCER;
MICRONUCLEUS;
MOUSE;
MUTAGENESIS;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
RAT;
TULAREMIA;
TUMOR GROWTH;
TUMOR REGRESSION;
TUMOR VOLUME;
UTERUS CANCER;
|
EID: 0036075059
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(02)00771-4 Document Type: Letter |
Times cited : (3)
|
References (11)
|